Down Syndrome Ds clinical trials

Explore recruiting down syndrome ds clinical trials.

Recruiting down syndrome ds studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Down Syndrome Ds trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer’s Disease (AD)

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Down Syndrome Ds trials by city

Down Syndrome Ds in Toronto Down Syndrome Ds in Vancouver Down Syndrome Ds in Montreal Down Syndrome Ds in Calgary Down Syndrome Ds in Edmonton Down Syndrome Ds in Ottawa Down Syndrome Ds in Winnipeg Down Syndrome Ds in Quebec City Down Syndrome Ds in Hamilton Down Syndrome Ds in Kitchener Down Syndrome Ds in London Down Syndrome Ds in Halifax Down Syndrome Ds in New York Down Syndrome Ds in Los Angeles Down Syndrome Ds in Chicago Down Syndrome Ds in Houston

Down Syndrome Ds clinical trials

Recruiting down syndrome ds studies right now

Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome

Effects of Powerball in Children With Down Syndrome

Suspension Therapy Effects on Mobility and Balance in Down Syndrome

The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

Adapting RDAD for DS

Physical Fitness in DS: A Comparison of Cuevas Medak and Rebound Exercises

Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome

Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

Pediatric Down Syndrome Post-Approval Study

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

The Effect of the HEP Approach in Infants With Down Syndrome

Using Technologies to Promote HEalthy Lifestyles in Adolescents With Intellectual Disabilities

Also recruiting in Europe

Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer’s Disease (AD)

Down Syndrome Ds trials by city

Other conditions